These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 35136975)

  • 21. Predictors of subclinical systemic sclerosis primary heart involvement characterised by microvasculopathy and myocardial fibrosis.
    Dumitru RB; Bissell LA; Erhayiem B; Fent G; Kidambi A; Swoboda P; Abignano G; Donica H; Burska A; Greenwood JP; Biglands J; Del Galdo F; Plein S; Buch MH
    Rheumatology (Oxford); 2021 Jun; 60(6):2934-2945. PubMed ID: 34080001
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Diffuse myocardial fibrosis precedes subclinical functional myocardial impairment and provides prognostic information in systemic sclerosis.
    Gotschy A; Jordan S; Stoeck CT; von Deuster C; Peer T; Gastl M; Vishnevskiy V; Wissmann L; Dobrota R; Mihai C; Becker MO; Maurer B; Kozerke S; Ruschitzka F; Distler O; Manka R
    Eur Heart J Cardiovasc Imaging; 2023 Feb; 24(3):373-382. PubMed ID: 35639682
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Relationship Between Ventricular Arrhythmias, Conduction Disorders, and Myocardial Fibrosis in Patients With Systemic Sclerosis.
    Muresan L; Oancea I; Mada RO; Petcu A; Pamfil C; Muresan C; Rinzis M; Pop D; Zdrenghea D; Rednic S
    J Clin Rheumatol; 2018 Jan; 24(1):25-33. PubMed ID: 29200022
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Electrical markers and arrhythmic risk associated with myocardial fibrosis in mitral valve prolapse.
    Chivulescu M; Aabel EW; Gjertsen E; Hopp E; Scheirlynck E; Cosyns B; Lyseggen E; Edvardsen T; Lie ØH; Dejgaard LA; Haugaa KH
    Europace; 2022 Jul; 24(7):1156-1163. PubMed ID: 35226070
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CMR feature tracking in cardiac asymptomatic systemic sclerosis: Clinical implications.
    Bratis K; Lindholm A; Hesselstrand R; Arheden H; Karabela G; Stavropoulos E; Katsifis G; Kolovou G; Kitas GD; Sfikakis PP; Koutsogeorgopoulou L; Mavrogeni S; Ostenfeld E
    PLoS One; 2019; 14(8):e0221021. PubMed ID: 31433819
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Application of cardiac magnetic resonance imaging in subclinical systemic sclerosis primary heart involvement].
    Zhao Z; Zhao YN; Jin JY; Yang JS; Zhu J; Li T
    Zhonghua Nei Ke Za Zhi; 2024 Feb; 63(2):176-182. PubMed ID: 38326044
    [No Abstract]   [Full Text] [Related]  

  • 27. Native T1 mapping in early diffuse and limited systemic sclerosis, and its association with diastolic function.
    Purevsuren M; Uehara M; Ishizuka M; Suzuki Y; Shimbo M; Kakuda N; Ishii S; Sumida H; Miyazaki M; Yamashita T; Yoshizaki A; Asano Y; Sato S; Hatano M; Komuro I
    J Cardiol; 2023 Aug; 82(2):100-107. PubMed ID: 36921691
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Myocardial fibrosis detected by magnetic resonance in systemic sclerosis patients - Relationship with biochemical and echocardiography parameters.
    Hromádka M; Seidlerová J; Suchý D; Rajdl D; Lhotský J; Ludvík J; Rokyta R; Baxa J
    Int J Cardiol; 2017 Dec; 249():448-453. PubMed ID: 28935460
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Digital Ulcers and Ventricular Arrhythmias as Red Flags to Predict Replacement Myocardial Fibrosis in Systemic Sclerosis.
    Gargani L; Bruni C; Todiere G; Pugliese NR; Bandini G; Bellando-Randone S; Guiducci S; D'Angelo G; Campochiaro C; De Luca G; Stagnaro C; Lombardi M; Dagna L; Pepe A; Allanore Y; Moggi-Pignone A; Matucci-Cerinic M
    J Clin Med; 2023 Dec; 13(1):. PubMed ID: 38202095
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diffuse myocardial fibrosis in patients with mitral valve prolapse and ventricular arrhythmia.
    Bui AH; Roujol S; Foppa M; Kissinger KV; Goddu B; Hauser TH; Zimetbaum PJ; Ngo LH; Manning WJ; Nezafat R; Delling FN
    Heart; 2017 Feb; 103(3):204-209. PubMed ID: 27515954
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Myocardial fibrosis imaging based on T1-mapping and extracellular volume fraction (ECV) measurement in muscular dystrophy patients: diagnostic value compared with conventional late gadolinium enhancement (LGE) imaging.
    Florian A; Ludwig A; Rösch S; Yildiz H; Sechtem U; Yilmaz A
    Eur Heart J Cardiovasc Imaging; 2014 Sep; 15(9):1004-12. PubMed ID: 24686257
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Decreased global myocardial perfusion at adenosine stress as a potential new biomarker for microvascular disease in systemic sclerosis: a magnetic resonance study.
    Gyllenhammar T; Kanski M; Engblom H; Wuttge DM; Carlsson M; Hesselstrand R; Arheden H
    BMC Cardiovasc Disord; 2018 Jan; 18(1):16. PubMed ID: 29382301
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Feasibility of Hepatic T1-Mapping and Extracellular Volume Quantification on Routine Cardiac Magnetic Resonance Imaging in Patients with Infiltrative and Systemic Disorders.
    Dolan RS; Stillman AE; Davarpanah AH
    Acad Radiol; 2022 Apr; 29 Suppl 4():S100-S109. PubMed ID: 34702675
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cardiac magnetic resonance in patients with mitral valve prolapse: Focus on late gadolinium enhancement and T1 mapping.
    Pradella S; Grazzini G; Brandani M; Calistri L; Nardi C; Mori F; Miele V; Colagrande S
    Eur Radiol; 2019 Mar; 29(3):1546-1554. PubMed ID: 30088066
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Detection of Left Ventricular Regional Dysfunction and Myocardial Abnormalities Using Complementary Cardiac Magnetic Resonance Imaging in Patients with Systemic Sclerosis without Cardiac Symptoms: A Pilot Study.
    Kobayashi Y; Kobayashi H; T Giles J; Yokoe I; Hirano M; Nakajima Y; Takei M
    Intern Med; 2016; 55(3):237-43. PubMed ID: 26831016
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Assessment of myocardial fibrosis and microvascular damage in systemic sclerosis by magnetic resonance imaging and coronary angiotomography.
    Rodríguez-Reyna TS; Morelos-Guzman M; Hernández-Reyes P; Montero-Duarte K; Martínez-Reyes C; Reyes-Utrera C; Vazquez-La Madrid J; Morales-Blanhir J; Núñez-Álvarez C; Cabiedes-Contreras J
    Rheumatology (Oxford); 2015 Apr; 54(4):647-54. PubMed ID: 25239881
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of age-related interstitial myocardial fibrosis with cardiac magnetic resonance contrast-enhanced T1 mapping: MESA (Multi-Ethnic Study of Atherosclerosis).
    Liu CY; Liu YC; Wu C; Armstrong A; Volpe GJ; van der Geest RJ; Liu Y; Hundley WG; Gomes AS; Liu S; Nacif M; Bluemke DA; Lima JAC
    J Am Coll Cardiol; 2013 Oct; 62(14):1280-1287. PubMed ID: 23871886
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Myocardial perfusion defects in scleroderma detected by contrast-enhanced cardiovascular magnetic resonance.
    Schicchi N; Valeri G; Moroncini G; Agliata G; Salvolini L; Gabrielli A; Giovagnoni A
    Radiol Med; 2014 Dec; 119(12):885-894. PubMed ID: 24907065
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characteristics and clinical relevance of late gadolinium enhancement in cardiac magnetic resonance in patients with systemic sclerosis.
    Sano M; Satoh H; Suwa K; Nobuhara M; Saitoh T; Saotome M; Urushida T; Katoh H; Shimoyama K; Suzuki D; Ogawa N; Takehara Y; Sakahara H; Hayashi H
    Heart Vessels; 2015 Nov; 30(6):779-88. PubMed ID: 24996373
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Myocardial fibrosis detected by magnetic resonance imaging, elevated U-CRP and higher mRSS are predictors of cardiovascular complications in systemic sclerosis (SSc) patients.
    Rodríguez-Reyna TS; Rosales-Uvera SG; Kimura-Hayama E; Hernández-Reyes P; Mercado-Velázquez P; Benavides-Suárez SA; Esquinca-González A; Núñez-Álvarez CA
    Semin Arthritis Rheum; 2019 Oct; 49(2):273-278. PubMed ID: 30853116
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.